Ultrasensitive CRISPR Platform Enables Rapid and Extraction-Free Detection of Viral Nucleic Acid
Analytical Chemistry · 2026
DOI: 10.1021/acs.analchem.5c06518 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Chi Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory, The Second Clinical Medical College (Shenzhen People's Hospital), Jinan University, Shenzhen, Guangdong 518020, Chi…. Hauptthemen laut MEDLINE: RNA, Viral, SARS-CoV-2, CRISPR-Cas Systems, COVID-19. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
CRISPR-based molecular diagnostics offers great potential for the rapid identification of pathogens. However, existing one-pot detection systems remain constrained by their restricted versatility and operational complexity. Herein, we report a novel strategy termed interspaced phosphorothioate primer-mediated one-pot detection (iPSOT), which substitutes conventional phosphodiester primers with interspaced phosphorothioate (iPS) primers. The iPS primers demonstrate strong compatibility with AapCas12b during loop-mediated isothermal amplification, enabling robust fluorescence signal generation within 15 min. The iPSOT system achieves highly specific nucleic acid detection and reliably identifies low-copy ribonucleic acid targets at concentrations of as low as 0.5 aM (0.3 copies/μL). Clinical validation further demonstrated that iPSOT enables the direct detection of SARS-CoV-2 from nasopharyngeal swabs without RNA extraction. This method reduces reagent cost and shortens assay time, achieving sample-to-result under 20 min. Overall, iPSOT enhances both sensitivity and specificity in one-pot detection and offers a promising platform for rapid, reliable point-of-care testing and large-scale pathogen surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory, The Second Clinical Medical College (Shenzhen People's Hospital), Jinan University, Shenzhen, Guangdong 518020, China.
- Integrated Chinese and Western Medicine Postdoctoral Research Station, Jinan University, Guangzhou 510632, China.
- Shenzhen Foreign Language Primary School, Shenzhen, Guangdong 518020, China.
- Faculty of Synthetic Biology, Shenzhen University of Advanced Technology, Shenzhen 518055, China.
- Department of Microbiology and Immunology, Basic Medicine College, Jinan University, Guangzhou 510632, China.
- Key Laboratory of Viral Pathogenesis & Infection Prevention and Control (Jinan University), Ministry of Education, Guangzhou 510632, China.
ORCID-Profile: Haofan Yin, Rui Gong, Xian-En Zhang
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Guangdong Provincial Clinical Research Center for Laboratory Medicine
- Five-Three Project for Training Clinician-Scientists of Shenzhen People's Hospital
- General project of Shenzhen Science and Technology Innovation Commission
- Major Project of Guangzhou National Laboratory
Zitieren
APA
Huang, C., Yang, Y., Yin, H., Chang, H., Gong, R., Jiang, Z., Zhang, X. E., & Chen, Y. (2026). Ultrasensitive CRISPR Platform Enables Rapid and Extraction-Free Detection of Viral Nucleic Acid. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c06518
Vancouver
Huang C, Yang Y, Yin H, Chang H, Gong R, Jiang Z, et al. Ultrasensitive CRISPR Platform Enables Rapid and Extraction-Free Detection of Viral Nucleic Acid. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.5c06518
BibTeX
@article{Huang2026,
author = {Huang, Chi and Yang, Yang and Yin, Haofan and Chang, Hao and Gong, Rui and Jiang, Zhenyou and Zhang, Xian-En and Chen, Yue},
title = {Ultrasensitive CRISPR Platform Enables Rapid and Extraction-Free Detection of Viral Nucleic Acid},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.5c06518}
}
EUVIMED